Coronary stents added to NLEM 2022

Published On 2022-11-21 12:11 GMT   |   Update On 2022-11-21 12:11 GMT
Advertisement

In a move to ensure affordable medical devices in the country, the Union health ministry has announced the inclusion of coronary stents in the National List of Essential Medicines, 2022.

The move is based on the recommendations by an expert committee constituted to review the inclusion of stents in the list based on the requirement.

The National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents. On November 6, the Standing National Committee on Medicines (SNCM) had submitted its recommendation for the inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022 in two categories - Bare Metal Stents (BMS) and Drug Eluting Stents (DES) which include metallic DES and bioresorbable vascular scaffold (VBS)/biodegradable stents.

For more details, check out the link given below:

Coronary Stents Now Included In NLEM 2022

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News